Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- MINIM, INC.
- TITAN PHARMACEUTICALS INC
Updated Jul 16, 2026
Ben-Tzvi Avraham has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | QUCY | Quantum Cyber N.V. | A — Grant or award | 137.1K | $0.00 | |
| 2026-01-23 | INDP | Indaptus Therapeutics, Inc. | A — Grant or award | 25.0K | $0.00 | |
| 2025-10-01 | TTNP | TITAN PHARMACEUTICALS INC | D — Derivative transaction | 3.3K | — | |
| 2024-10-01 | FIEE | MINIM, INC. | A — Grant or award | 159.4K | — |
Ben-Tzvi Avraham is a corporate insider — currently tracked as Director of Quantum Cyber N.V. (QUCY). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ben-Tzvi Avraham profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.